In this week's edition of the KLJ Blog, Staff Editor Samuel L. Hoops highlights the price-gouging of EpiPens by Mylan Inc., and considers the possible ramifications of this practice under the Racketeer Influenced and Corrupt Organizations (“RICO”) Act.